Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Encompass Health reports robust Q4 performance amidst operational challenges

Encompass Health delivered a strong performance in Q4 2022, showcasing financial growth, effective cost management, and strategic investments in hospital expansions.
While facing challenges such as administrative delays in de novo hospitals and fluctuations in case mix, the company remains focused on leveraging opportunities in market density and regulatory engagement.
With a clear focus on financial stability, growth opportunities, and strategic planning, Encompass Health aims to navigate industry challenges and drive future success.

Encompass Health reports strong Q1 earnings, eyes growth opportunities

Encompass Health (EHC) delivered a robust performance in Q1 2023, showcasing financial growth and operational efficiency.
While facing challenges in labor expenses and capacity constraints, the company remains focused on growth strategies and maintaining strong financial performance.
With raised guidance for 2023 and investments in technology, Encompass Health is poised to capitalize on opportunities for market expansion and improved patient outcomes.

Encompass Health reports robust Q2 earnings, eyes Medicare Advantage growth

Encompass Health's Q2 performance showcased strong revenue and EBITDA growth, driven by volume increases and cost efficiencies. The company's focus on strategic investments, capacity expansions, and optimizing Medicare Advantage revenues positions it well for future growth. Challenges in managing occupancy rates and potential Medicare payment structure changes require careful monitoring.

Encompass Health reports robust Q3 results amid labor cost reductions

Encompass Health's Q3 performance showcased strong revenue growth, operational efficiency, and effective cost management strategies.
The company's focus on key patient categories and capacity expansions position it well for future growth and market relevance.
While challenges like labor market dynamics persist, Encompass Health's strategic initiatives and financial outlook remain positive.

Encompass Health reports robust Q4 performance amidst growth investments

Encompass Health's Q4 2023 performance reflects strong financial growth, operational efficiency, and strategic investments, positioning the company for continued success.
While challenges such as labor inflation and margin sustainability persist, the company's focus on clinical innovation and readiness for regulatory changes bode well for future growth.
Opportunities in managed care, value-based arrangements, and expansion plans offer Encompass Health avenues for further development and enhancing its value proposition in the healthcare sector.

Encompass Health excels in Q1, poised for strategic growth

Encompass Health's Q1 performance reflects robust growth, operational resilience, and strategic foresight amidst industry challenges.
The company's focus on clinical excellence, capacity expansion, and financial discipline positions it for sustained success and market leadership.
While facing cybersecurity risks and regulatory uncertainties, Encompass Health's proactive approach and strong fundamentals mitigate potential challenges.
Encompass Health's upwardly revised guidance, strong patient volume trends, and investment in technology underscore its commitment to growth and innovation.

Encompass Health excels in Q3 2024, poised for growth

Encompass Health's Q3 2024 performance reflects robust revenue growth, operational efficiency, and strategic investments in capacity expansion.
The company's financial strength, resilience to operational challenges, and focus on innovation position it well for future growth opportunities.
While facing potential challenges in a dynamic healthcare landscape, Encompass Health has opportunities to drive growth through strategic initiatives and market expansion.
Overall, Encompass Health's strong performance, prudent financial management, and growth outlook make it a compelling player in the healthcare industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Encompass Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.

Stock Upgrades: Encompass Health Shows Robust Strength Amid Expansion Moves

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?

Why Is Encompass Health (EHC) Down 3.2% Since Last Earnings Report?

Encompass Health Corporation (EHC) CEO Mark Tarr on Q4 2019 Results - Earnings Call Transcript

Encompass Health (EHC) delivered earnings and revenue surprises of -2.30% and -0.14%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Encompass Health (EHC) Q4 Earnings and Revenues Lag Estimates

Let's see if Encompass Health Corporation (EHC) stock is a good choice for value-oriented investors right now from multiple angles.

Should Value Investor Pick Encompass Health (EHC) Stock Now?

Encompass Health Corporation (EHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Encompass Health Corporation (EHC) is Poised to Beat Earnings Estimates Again

U.S. Physical Therapy

EHC vs. USPH: Which Stock Is the Better Value Option?

EHC or USPH: Which Is the Better Value Stock Right Now?

Brookdale Senior Living

Cigna

Fresenius Medical Care

HCA Healthcare

Healthcare Services Group

MEDNAX

The doctor is ordering you to protect your portfolio by avoiding these seven healthcare stocks. There are better investments elsewhere.

7 Sickly Healthcare Stocks to Avoid

Encompass Health Corp (EHC) CEO April Anthony on Q3 2019 Results - Earnings Call Transcript

Encompass Health (EHC) delivered earnings and revenue surprises of 4.49% and 0.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Encompass Health (EHC) Q3 Earnings and Revenues Top Estimates

Encompass Health (EHC) stock may be a good choice for value-oriented investors right now from multiple angles.

Can Value Investors Consider Encompass Health (EHC) Stock?

Encompass Health Corporation (EHC) CEO Mark Tarr on Q2 2019 Results - Earnings Call Transcript

Encompass Health Corporation (EHC) CEO Mark Tarr on Q1 2019 Results - Earnings Call Transcript

The integrated healthcare company achieved solid growth in the first quarter with its rehab, home health, and hospice businesses.

News for Encompass Health Stock (EHC)